Shares of Apple rallied on Friday, with the stock hitting a record after it was reported that Warren Buffett’s company bought 75 million shares of the iPhone maker over the first quarter. The stock
Buying beaten down biotech stocks is a strategy I focus on, especially at the end of each year because as tax loss selling fades, it is possible to see very strong gains into the New Year. For example, last December, I wrote an article about Immunogen (IMGN) titled “Why This $1 Biotech Stock Is A Strong Buy Now” and that stock went to over $8.50 per share in 2017. Almost a year ago,....More>>>
Sometimes a company pieces together a body of strategic and developmental work, explains its story — and progress — to the market, and investors slowly fall in love with the idea and gradually turn the heat up on the stock.
This is not one of those times. Although Cell MedX Corp (OTCMKTS:CMXC) has a great backstory, the chart came alive yesterday like someone flipped a switch.....More>>>
After reporting much better than expected results for its third quarter fiscal 2017 ended October 30,NVIDIA (NSDQ:NVDA)has continued to build new markets signing new collaborations with the tech giantsMicrosoft (NSDQ:MSFT)and International Business Machines (NYSE:IBM). In my view, these new developments will enable NVIDIA to maintain its impressive growth and to drive its shares even higher.
The copper (NYSEARCA:JJC) rally at the end of October / beginning of November was violent; 30% in 13 sessions on the back of the election and an epic short squeeze. Unfortunately this kind of move isn’t usually sustainable and a pullback / consolidation after such a move is normal.
This was also the case for Freeport-McMoRan (NYSE:FCX). I warned on November 28th not to chase the rally.....More>>>
Inspired by reports that OPEC had come to an agreement to curb its oil output as a means of propping up floundering crude prices, stocks got Wednesday started on a rather bullish foot. They just didn’t end it that way. By the time the closing bell rang, the S&P 500 was back in the red by 0.27%, closing at 2,198.81.
It was even worse for shareholders of Valeant Pharmaceuticals Intl....More>>>
On May 9, wireless technology giantQualcomm(NASDAQ:QCOM) announced a new stock repurchase program for $10 billion of the company's shares. This program, the company said, replaces a previous buyback authorization that had $1.2 billion remaining (so the net increase in Qualcomm's buyback firepower
Editor's Note: Options are a great way to "insure" your portfolio against sudden price drops. With Tom's strategy, you can make markets pay for that "insurance," cutting your risk even more. Here's Tom…
We've looked before at twoways to make money when interes
On a busy day for bank earnings, Citigroup (NYSE:C) was one of three big U.S. banks to report results, and despite an earnings beat, the report wasn't great. While the bank's efficiency was strong and loans and deposits grew, the bank missed expectations in several key areas, including trading r
Headlines about Aldeyra Therapeutics (NASDAQ:ALDX) have trended somewhat positive on Saturday, Accern Sentiment reports. Accern identifies negative and positive press coverage by monitoring more than 20 million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies
One is known as one of the first online brokers, and the other is famous for pioneering index funds, but they both help millions of people save for retirement with IRAs. In this article, we'll compare E*Trade's and Vanguard'sIRA accounts, based on factors like commissions, account fees, and inves